These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prevalence, tumorigenic role, and biochemical implications of rare BRAF alterations. Barollo S; Pezzani R; Cristiani A; Redaelli M; Zambonin L; Rubin B; Bertazza L; Zane M; Mucignat-Caretta C; Bulfone A; Pennelli G; Casal Ide E; Pelizzo MR; Mantero F; Moro S; Mian C Thyroid; 2014 May; 24(5):809-19. PubMed ID: 24295088 [TBL] [Abstract][Full Text] [Related]
6. Follicular variant of papillary thyroid carcinoma with B-type Raf(V600E) showing higher frequency of suspicious sonographic features and multifocality. Shin DY; Kim KJ; Chang S; Kim H; Hwang S; Kim W; Bae J; Park S; Kang SW; Chung WY; Lee EJ Head Neck; 2015 Nov; 37(11):1590-5. PubMed ID: 24909403 [TBL] [Abstract][Full Text] [Related]
12. Occult oncocytic papillary thyroid carcinoma with lymphoid stroma (Warthin-like tumor): report of a case with concomitant mutations of BRAF V600E and V600K. Han F; Zhang L; Zhang S; Zhou H; Yi X Int J Clin Exp Pathol; 2015; 8(5):5896-901. PubMed ID: 26191315 [TBL] [Abstract][Full Text] [Related]
13. [BRAF V600E mutation in papillary thyroid carcinoma: prevalence and detection in fine needle aspiration specimens]. Dujardin F; Pagès JC; Collin C; de Calan L; Lecomte P; Guyétant S Ann Pathol; 2010 Aug; 30(4):252-62. PubMed ID: 20837233 [TBL] [Abstract][Full Text] [Related]
14. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates. Marchetti I; Lessi F; Mazzanti CM; Bertacca G; Elisei R; Coscio GD; Pinchera A; Bevilacqua G Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623 [TBL] [Abstract][Full Text] [Related]
15. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study. Joo JY; Park JY; Yoon YH; Choi B; Kim JM; Jo YS; Shong M; Koo BS J Clin Endocrinol Metab; 2012 Nov; 97(11):3996-4003. PubMed ID: 22930785 [TBL] [Abstract][Full Text] [Related]
16. Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers. Liu Z; Hou P; Ji M; Guan H; Studeman K; Jensen K; Vasko V; El-Naggar AK; Xing M J Clin Endocrinol Metab; 2008 Aug; 93(8):3106-16. PubMed ID: 18492751 [TBL] [Abstract][Full Text] [Related]